Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Mutations in FAM105B gene may be involved in autoinflammatory diseases

Nov. 29, 2016

Actelion Pharmaceuticals describes TPHI1 inhibitors

Nov. 22, 2016

Eagle Pharmaceuticals initiates rolling NDA for Ryanodex in EHS

Nov. 14, 2016

University of California develops anti-alphavbeta1 integrin inhibitors

Sep. 28, 2016

NIH grants support work at Feinstein Institute on bioelectronic medicine and sepsis

Aug. 19, 2016

Hutchison MediPharma patents PI3K inhibitors

Aug. 18, 2016

SAMD9 mutations cause new form of syndromic adrenal hypoplasia

July 29, 2016

InflaRx raises funds in series C financing

July 25, 2016

Mutations in TRMT10C identified as a cause of mitochondrial disease

July 15, 2016

Animal model studies give insight into mechanisms of disease

June 6, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.